Verve Therapeutics takeover has 'positive readthrough' for gene editing space - BMO Capital Jun 17, 2025 11:28AM
BMO Capital Starts Metagenomi Inc (MGX) at Outperform, 'One-Stop Platform for Metagenomics-Derived Gene Editing' Mar 5, 2024 03:37AM
Metagenomi (MGX) Closes $93.75M IPO Feb 13, 2024 04:36PM
Metagenomi Announces Closing of Initial Public Offering Feb 13, 2024 04:35PM
Metagenomi (MGX) Prices 6.25M Share IPO at $15/sh Feb 9, 2024 02:27AM


Feb 8, 2024 10:16PM Metagenomi Announces Pricing of Initial Public Offering
Jan 5, 2024 05:22PM Metagenomi (MGX) Announces Proposed IPO